Clorox (NYSE:CLX) Given New $150.00 Price Target at Citigroup

Clorox (NYSE:CLX) had its price objective reduced by Citigroup from $155.00 to $150.00 in a research note issued to investors on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the stock.

CLX has been the topic of several other reports. DA Davidson reissued a neutral rating and set a $162.00 price target on shares of Clorox in a report on Wednesday, April 17th. Jefferies Financial Group raised shares of Clorox from an underperform rating to a hold rating and set a $145.00 price objective on the stock in a report on Tuesday, March 26th. Morgan Stanley reaffirmed an equal weight rating and set a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. The Goldman Sachs Group began coverage on shares of Clorox in a research note on Friday, March 1st. They set a sell rating and a $140.00 price target on the stock. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on Clorox from $155.00 to $151.00 and set a hold rating for the company in a research note on Wednesday, April 17th. Four investment analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of Hold and a consensus price target of $146.43.

Clorox Trading Down 1.0 %

Clorox stock opened at $138.23 on Wednesday. Clorox has a one year low of $114.68 and a one year high of $176.24. The business’s fifty day moving average is $148.45 and its 200 day moving average is $143.17. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.57. The stock has a market capitalization of $17.17 billion, a PE ratio of 71.62, a price-to-earnings-growth ratio of 2.16 and a beta of 0.44.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Tuesday, April 30th. The company reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. The firm had revenue of $1.81 billion during the quarter, compared to analyst estimates of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The business’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same period in the previous year, the business posted $1.51 earnings per share. On average, sell-side analysts predict that Clorox will post 5.83 EPS for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Investors of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 annualized dividend and a yield of 3.47%. Clorox’s payout ratio is 248.71%.

Institutional Trading of Clorox

Several hedge funds have recently bought and sold shares of the stock. Kingswood Wealth Advisors LLC purchased a new position in Clorox during the 3rd quarter valued at approximately $484,000. Robeco Institutional Asset Management B.V. grew its holdings in shares of Clorox by 11.5% in the third quarter. Robeco Institutional Asset Management B.V. now owns 321,219 shares of the company’s stock valued at $42,099,000 after purchasing an additional 33,044 shares in the last quarter. Xponance Inc. increased its position in Clorox by 2.5% in the third quarter. Xponance Inc. now owns 29,343 shares of the company’s stock worth $3,846,000 after purchasing an additional 726 shares during the last quarter. Dakota Wealth Management lifted its position in Clorox by 20.0% during the third quarter. Dakota Wealth Management now owns 2,642 shares of the company’s stock valued at $346,000 after purchasing an additional 440 shares during the last quarter. Finally, Raymond James & Associates increased its holdings in shares of Clorox by 8.0% in the 3rd quarter. Raymond James & Associates now owns 306,613 shares of the company’s stock worth $40,185,000 after buying an additional 22,597 shares during the last quarter. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.